Rivaroksaban shortage status
2 active shortage notices across 1 country.
Last updated 2 Aug 2026 · sourced from official medicines regulators
- Generic name (INN)
- Rivaroksaban
- Brand names
- Rivaxa
- Class
- Auto-created by NoMA (Norwegian Medicines Agency / DMP) scraper
Where Rivaroksaban is in shortage
Why Rivaroksaban is in shortage
- manufacturing problems — e.g. “razlozi povezani s proizvodnjom” (Croatia)
Recent shortage history
- Norway: resolved 26 Feb 2026 (began 21 Jan 2026)
Frequently asked questions
Is Rivaroksaban currently in shortage?
Yes. As of the latest regulator updates, Rivaroksaban has 2 active shortage notices across 1 country (Croatia). Status is refreshed daily from official regulatory sources.
Why is Rivaroksaban in shortage?
Regulators attribute the current Rivaroksaban shortages to manufacturing problems. The exact cause varies by country and product — each notice on this page links to the official source.
Where does this Rivaroksaban shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.
Get alerted when Rivaroksaban status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Create a free accountData on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.